MedTechIQ_3Helix InSight Engine-Beta
Preview
Open in TheBrain
Triple Helix Discovery Engine
Triple Helix Framework
Industry
Architects: Small & Medium Size Business (SMBs), Product Development, De-Risking, Validation, Building Niche & Emerging Markets
*Architects: Gastroenterology_Gastrointestinal (to include Liver, Pancreas & metabolic dysfunction-associated steatotic liver disease (MASLD), Gout, MASH (Metabolic dysfunction-associated steatohepatitis), formerly, NASH (Non-Alcoholic SteatoHepatitis)Non-Alcoholic SteatoHepatitis (NASH)
Gyre Therapeutics Inc. (NASDAQ: GYRE)*
Organization & Developments: Gyre Therapeutics
Parents
Gyre Therapeutics Inc. (NASDAQ: GYRE)*
Children
2024: Gyre Therapeutics: Under The Radar Biotech Has A Shot At MASH Approval, In Time
2025: Gyre: Intriguing Upcoming Data Catalyst, But I'm Still On Sidelines
Catalyst Biosciences, Inc (NASDAQ: CBIO)
GNI Group
Jumps
Finance & Acquisition: Gyre Therapeutics
Key People: Gyre Therapeutics